BioCentury
ARTICLE | Company News

Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers, Eli Lilly, GlaxoSmithKline, J&J, Roche, Sanofi pharmaceuticals news

September 24, 2012 7:00 AM UTC

The pharmas and Roche's Genentech Inc. unit launched TransCelerate BioPharma Inc. (Philadelphia, Pa.), a not-for-profit that seeks to identify and solve common drug development challenges to improve the quality of clinical trials and accelerate drug development. The company will initially focus on improving clinical trial execution through five projects: development of a shared user interface for investigator site portals; mutual recognition of study site qualification and training; development of risk-based site monitoring approaches and standards; development of clinical data standards; and establishment of a comparator drug supply model. TransCelerate expects to meet undisclosed milestones for each project by mid-2013. ...